Table 2. Disease manifestations*.

Case history details	Values
Site
Genital, % (n)	49.0 % (146/298)
of which exclusively genital, % (n)	45.2 % (66/146)
Anal, % (n)	50.8 % (152/299)
of which exclusively anal, % (n)	35.5 % (54/152)
Oral, perioral, head, % (n)	24.4 % (72/296)
of which exclusively oral/head, % (n)	33.3 % (24/72)
Extremities and/or trunk, % (n)	41.7 % (122/292)
of which exclusively, % (n)	13.1 % (16/122)
Number of lesions
none (only positive swabs), % (n)	1.1 % (3/279)
1–3, % (n)	44.1 % (123/279)
4–10, % (n)	33.3 % (93/279)
11–50, % (n)	18.3 % (51/279)
>50, % (n)	3.2 % (9/279)
General symptoms
Fever, % (n)	61.3 % (168/274)
Headache and aching limbs, % (n)	46.7 % (126/270)
Night sweats, % (n)	19.9 % (53/266)
Lymph node swelling, % (n)	44.1 % (116/263)

* in each case, only cases with available information listed